nodes	percent_of_prediction	percent_of_DWPC	metapath
Candesartan—CYP2C8—Tazarotene—psoriasis	0.141	0.214	CbGbCtD
Candesartan—CYP2C8—Cholecalciferol—psoriasis	0.06	0.0913	CbGbCtD
Candesartan—CYP2C8—Mycophenolate mofetil—psoriasis	0.052	0.0792	CbGbCtD
Candesartan—CYP2C9—Cholecalciferol—psoriasis	0.0418	0.0637	CbGbCtD
Candesartan—CYP2C8—Hydrocortisone—psoriasis	0.0417	0.0635	CbGbCtD
Candesartan—CYP2C8—Cyclosporine—psoriasis	0.0394	0.06	CbGbCtD
Candesartan—ABCB1—Mycophenolate mofetil—psoriasis	0.0352	0.0536	CbGbCtD
Candesartan—ABCB1—Betamethasone—psoriasis	0.0302	0.046	CbGbCtD
Candesartan—ABCB1—Prednisolone—psoriasis	0.0298	0.0454	CbGbCtD
Candesartan—ABCB1—Hydrocortisone—psoriasis	0.0283	0.043	CbGbCtD
Candesartan—ABCB1—Prednisone—psoriasis	0.0281	0.0428	CbGbCtD
Candesartan—CYP2C9—Cyclosporine—psoriasis	0.0275	0.0418	CbGbCtD
Candesartan—ABCB1—Cyclosporine—psoriasis	0.0267	0.0406	CbGbCtD
Candesartan—CYP2C8—Dexamethasone—psoriasis	0.026	0.0395	CbGbCtD
Candesartan—CYP2C9—Dexamethasone—psoriasis	0.0181	0.0276	CbGbCtD
Candesartan—ABCB1—Dexamethasone—psoriasis	0.0176	0.0267	CbGbCtD
Candesartan—ABCB1—Methotrexate—psoriasis	0.0141	0.0215	CbGbCtD
Candesartan—Pranlukast—NFKB1—psoriasis	0.00534	0.446	CrCbGaD
Candesartan—AGTR1—Allograft Rejection—IL22—psoriasis	0.00443	0.0823	CbGpPWpGaD
Candesartan—AGTR1—ACE Inhibitor Pathway—REN—psoriasis	0.00379	0.0703	CbGpPWpGaD
Candesartan—CYP2C8—CYP2E1 reactions—CYP2S1—psoriasis	0.003	0.0557	CbGpPWpGaD
Candesartan—Irbesartan—JUN—psoriasis	0.00292	0.243	CrCbGaD
Candesartan—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.00244	0.0454	CbGpPWpGaD
Candesartan—AGTR1—ACE Inhibitor Pathway—ACE—psoriasis	0.00236	0.0439	CbGpPWpGaD
Candesartan—CYP2C8—Xenobiotics—CYP2S1—psoriasis	0.00186	0.0345	CbGpPWpGaD
Candesartan—Pranlukast—TNF—psoriasis	0.00164	0.137	CrCbGaD
Candesartan—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.00151	0.0281	CbGpPWpGaD
Candesartan—Telmisartan—PPARG—psoriasis	0.00141	0.118	CrCbGaD
Candesartan—ABCB1—Allograft Rejection—IL22—psoriasis	0.0013	0.0242	CbGpPWpGaD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.00102	0.0189	CbGpPWpGaD
Candesartan—PTGS1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00097	0.018	CbGpPWpGaD
Candesartan—UGT1A3—Biological oxidations—CYP2S1—psoriasis	0.000915	0.017	CbGpPWpGaD
Candesartan—UGT1A3—Metapathway biotransformation—CYP2S1—psoriasis	0.000902	0.0167	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—HLA-C—psoriasis	0.00084	0.0156	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—IL13—psoriasis	0.000835	0.0155	CbGpPWpGaD
Candesartan—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000773	0.0143	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—IL17A—psoriasis	0.000768	0.0143	CbGpPWpGaD
Candesartan—CYP2C8—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000763	0.0142	CbGpPWpGaD
Candesartan—PTGS1—Overview of nanoparticle effects—CRP—psoriasis	0.000716	0.0133	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—IL12B—psoriasis	0.000714	0.0133	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—HLA-E—psoriasis	0.000697	0.0129	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	0.000677	0.0126	CbGpPWpGaD
Candesartan—Losartan—ACE—psoriasis	0.000673	0.0562	CrCbGaD
Candesartan—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000629	0.0117	CbGpPWpGaD
Candesartan—CYP2C8—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000627	0.0116	CbGpPWpGaD
Candesartan—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000621	0.0115	CbGpPWpGaD
Candesartan—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000539	0.01	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—CCL20—psoriasis	0.000524	0.00973	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—IL10—psoriasis	0.000522	0.00969	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—HCAR2—psoriasis	0.000515	0.00956	CbGpPWpGaD
Candesartan—PTGS1—Biological oxidations—CYP2S1—psoriasis	0.000515	0.00956	CbGpPWpGaD
Candesartan—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00051	0.00947	CbGpPWpGaD
Candesartan—UGT1A3—NRF2 pathway—TGFA—psoriasis	0.000509	0.00945	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—IL4—psoriasis	0.000508	0.00943	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—HLA-B—psoriasis	0.000497	0.00922	CbGpPWpGaD
Candesartan—PTGS1—Overview of nanoparticle effects—CXCL8—psoriasis	0.000466	0.00864	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—HLA-A—psoriasis	0.00046	0.00854	CbGpPWpGaD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	0.000438	0.00814	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—HLA-DRB1—psoriasis	0.000421	0.00781	CbGpPWpGaD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	0.000379	0.00703	CbGpPWpGaD
Candesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NFKB1—psoriasis	0.000368	0.00684	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.000352	0.00652	CbGpPWpGaD
Candesartan—CYP2C8—Biological oxidations—CYP2S1—psoriasis	0.000333	0.00618	CbGpPWpGaD
Candesartan—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	0.000328	0.00609	CbGpPWpGaD
Candesartan—PTGS1—Overview of nanoparticle effects—TNF—psoriasis	0.000324	0.00602	CbGpPWpGaD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	0.000319	0.00593	CbGpPWpGaD
Candesartan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000309	0.00574	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—IFNG—psoriasis	0.000307	0.0057	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—HCAR2—psoriasis	0.000291	0.00541	CbGpPWpGaD
Candesartan—Angioedema—Hydrocortisone—psoriasis	0.00029	0.00105	CcSEcCtD
Candesartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000289	0.00536	CbGpPWpGaD
Candesartan—Back pain—Triamcinolone—psoriasis	0.000289	0.00104	CcSEcCtD
Candesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—psoriasis	0.000287	0.00532	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—CXCL8—psoriasis	0.000286	0.0053	CbGpPWpGaD
Candesartan—Thrombocytopenia—Cyclosporine—psoriasis	0.000285	0.00103	CcSEcCtD
Candesartan—Vertigo—Hydrocortisone—psoriasis	0.000285	0.00103	CcSEcCtD
Candesartan—Body temperature increased—Mycophenolic acid—psoriasis	0.000284	0.00103	CcSEcCtD
Candesartan—Abdominal pain—Mycophenolic acid—psoriasis	0.000284	0.00103	CcSEcCtD
Candesartan—Dizziness—Hydroxyurea—psoriasis	0.000284	0.00103	CcSEcCtD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	0.000284	0.00527	CbGpPWpGaD
Candesartan—Hyperhidrosis—Cyclosporine—psoriasis	0.000281	0.00102	CcSEcCtD
Candesartan—Hypertension—Prednisolone—psoriasis	0.00028	0.00101	CcSEcCtD
Candesartan—Thrombocytopenia—Mycophenolate mofetil—psoriasis	0.000278	0.001	CcSEcCtD
Candesartan—Tachycardia—Mycophenolate mofetil—psoriasis	0.000277	0.001	CcSEcCtD
Candesartan—Hyperhidrosis—Mycophenolate mofetil—psoriasis	0.000275	0.000991	CcSEcCtD
Candesartan—Hypertension—Hydrocortisone—psoriasis	0.000274	0.000988	CcSEcCtD
Candesartan—Vomiting—Hydroxyurea—psoriasis	0.000273	0.000986	CcSEcCtD
Candesartan—Angioedema—Triamcinolone—psoriasis	0.000273	0.000985	CcSEcCtD
Candesartan—Haemoglobin—Prednisone—psoriasis	0.000272	0.000983	CcSEcCtD
Candesartan—Haemorrhage—Prednisone—psoriasis	0.000271	0.000978	CcSEcCtD
Candesartan—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.000271	0.00503	CbGpPWpGaD
Candesartan—Rash—Hydroxyurea—psoriasis	0.000271	0.000978	CcSEcCtD
Candesartan—Dermatitis—Hydroxyurea—psoriasis	0.000271	0.000977	CcSEcCtD
Candesartan—Myalgia—Hydrocortisone—psoriasis	0.00027	0.000974	CcSEcCtD
Candesartan—Headache—Hydroxyurea—psoriasis	0.000269	0.000972	CcSEcCtD
Candesartan—Anxiety—Hydrocortisone—psoriasis	0.000269	0.000971	CcSEcCtD
Candesartan—Vertigo—Triamcinolone—psoriasis	0.000268	0.000968	CcSEcCtD
Candesartan—AGTR1—GPCR ligand binding—CCL20—psoriasis	0.000268	0.00497	CbGpPWpGaD
Candesartan—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.000267	0.00496	CbGpPWpGaD
Candesartan—Hypotension—Mycophenolate mofetil—psoriasis	0.000265	0.000958	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.000265	0.000957	CcSEcCtD
Candesartan—PTGS1—Selenium Micronutrient Network—CAT—psoriasis	0.000265	0.00491	CbGpPWpGaD
Candesartan—Neutropenia—Methotrexate—psoriasis	0.000265	0.000955	CcSEcCtD
Candesartan—AGTR1—Signaling by GPCR—HCAR2—psoriasis	0.000264	0.00491	CbGpPWpGaD
Candesartan—Upper respiratory tract infection—Methotrexate—psoriasis	0.000263	0.000949	CcSEcCtD
Candesartan—PTGS1—Overview of nanoparticle effects—IL6—psoriasis	0.000262	0.00486	CbGpPWpGaD
Candesartan—Paraesthesia—Cyclosporine—psoriasis	0.000261	0.000944	CcSEcCtD
Candesartan—Cough—Triamcinolone—psoriasis	0.00026	0.00094	CcSEcCtD
Candesartan—Dyspnoea—Cyclosporine—psoriasis	0.00026	0.000937	CcSEcCtD
Candesartan—Somnolence—Cyclosporine—psoriasis	0.000259	0.000934	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.000259	0.000934	CcSEcCtD
Candesartan—Tachycardia—Prednisolone—psoriasis	0.000259	0.000933	CcSEcCtD
Candesartan—Asthenia—Mycophenolic acid—psoriasis	0.000258	0.000932	CcSEcCtD
Candesartan—Hypertension—Triamcinolone—psoriasis	0.000258	0.00093	CcSEcCtD
Candesartan—Dyspepsia—Cyclosporine—psoriasis	0.000256	0.000925	CcSEcCtD
Candesartan—Hyperhidrosis—Prednisolone—psoriasis	0.000256	0.000924	CcSEcCtD
Candesartan—Nausea—Hydroxyurea—psoriasis	0.000255	0.000921	CcSEcCtD
Candesartan—Paraesthesia—Mycophenolate mofetil—psoriasis	0.000255	0.000921	CcSEcCtD
Candesartan—Pruritus—Mycophenolic acid—psoriasis	0.000255	0.000919	CcSEcCtD
Candesartan—Myalgia—Triamcinolone—psoriasis	0.000254	0.000917	CcSEcCtD
Candesartan—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000253	0.000914	CcSEcCtD
Candesartan—Tachycardia—Hydrocortisone—psoriasis	0.000252	0.000912	CcSEcCtD
Candesartan—Somnolence—Mycophenolate mofetil—psoriasis	0.000252	0.000911	CcSEcCtD
Candesartan—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000251	0.000907	CcSEcCtD
Candesartan—Fatigue—Cyclosporine—psoriasis	0.000251	0.000906	CcSEcCtD
Candesartan—Hyperhidrosis—Hydrocortisone—psoriasis	0.00025	0.000903	CcSEcCtD
Candesartan—Dyspepsia—Mycophenolate mofetil—psoriasis	0.00025	0.000902	CcSEcCtD
Candesartan—Renal failure—Methotrexate—psoriasis	0.000248	0.000895	CcSEcCtD
Candesartan—Angioedema—Betamethasone—psoriasis	0.000247	0.000893	CcSEcCtD
Candesartan—Angioedema—Dexamethasone—psoriasis	0.000247	0.000893	CcSEcCtD
Candesartan—ABCB1—Allograft Rejection—HLA-C—psoriasis	0.000247	0.00458	CbGpPWpGaD
Candesartan—Diarrhoea—Mycophenolic acid—psoriasis	0.000246	0.000889	CcSEcCtD
Candesartan—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000245	0.000885	CcSEcCtD
Candesartan—ABCB1—Allograft Rejection—IL13—psoriasis	0.000245	0.00455	CbGpPWpGaD
Candesartan—Vertigo—Dexamethasone—psoriasis	0.000243	0.000878	CcSEcCtD
Candesartan—Vertigo—Betamethasone—psoriasis	0.000243	0.000878	CcSEcCtD
Candesartan—Hypotension—Hydrocortisone—psoriasis	0.000242	0.000873	CcSEcCtD
Candesartan—Haematuria—Methotrexate—psoriasis	0.00024	0.000868	CcSEcCtD
Candesartan—Gastrointestinal pain—Cyclosporine—psoriasis	0.000238	0.000859	CcSEcCtD
Candesartan—Dizziness—Mycophenolic acid—psoriasis	0.000238	0.000859	CcSEcCtD
Candesartan—Epistaxis—Methotrexate—psoriasis	0.000238	0.000859	CcSEcCtD
Candesartan—Paraesthesia—Prednisolone—psoriasis	0.000238	0.000859	CcSEcCtD
Candesartan—Tachycardia—Triamcinolone—psoriasis	0.000238	0.000858	CcSEcCtD
Candesartan—Mental disorder—Prednisone—psoriasis	0.000237	0.000857	CcSEcCtD
Candesartan—Malnutrition—Prednisone—psoriasis	0.000236	0.000851	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000236	0.000851	CcSEcCtD
Candesartan—Hyperhidrosis—Triamcinolone—psoriasis	0.000235	0.00085	CcSEcCtD
Candesartan—Agranulocytosis—Methotrexate—psoriasis	0.000235	0.00085	CcSEcCtD
Candesartan—Hypertension—Betamethasone—psoriasis	0.000234	0.000844	CcSEcCtD
Candesartan—Hypertension—Dexamethasone—psoriasis	0.000234	0.000844	CcSEcCtD
Candesartan—Paraesthesia—Hydrocortisone—psoriasis	0.000232	0.000839	CcSEcCtD
Candesartan—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000232	0.000838	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—VEGFA—psoriasis	0.000232	0.0043	CbGpPWpGaD
Candesartan—Urticaria—Cyclosporine—psoriasis	0.000231	0.000835	CcSEcCtD
Candesartan—Myalgia—Betamethasone—psoriasis	0.000231	0.000832	CcSEcCtD
Candesartan—Myalgia—Dexamethasone—psoriasis	0.000231	0.000832	CcSEcCtD
Candesartan—Body temperature increased—Cyclosporine—psoriasis	0.00023	0.000831	CcSEcCtD
Candesartan—Abdominal pain—Cyclosporine—psoriasis	0.00023	0.000831	CcSEcCtD
Candesartan—Anxiety—Betamethasone—psoriasis	0.00023	0.00083	CcSEcCtD
Candesartan—Anxiety—Dexamethasone—psoriasis	0.00023	0.00083	CcSEcCtD
Candesartan—Vomiting—Mycophenolic acid—psoriasis	0.000229	0.000826	CcSEcCtD
Candesartan—Dyspepsia—Hydrocortisone—psoriasis	0.000228	0.000822	CcSEcCtD
Candesartan—Haemoglobin—Methotrexate—psoriasis	0.000228	0.000822	CcSEcCtD
Candesartan—Rash—Mycophenolic acid—psoriasis	0.000227	0.000819	CcSEcCtD
Candesartan—Dermatitis—Mycophenolic acid—psoriasis	0.000227	0.000818	CcSEcCtD
Candesartan—Hepatitis—Methotrexate—psoriasis	0.000226	0.000817	CcSEcCtD
Candesartan—Haemorrhage—Methotrexate—psoriasis	0.000226	0.000817	CcSEcCtD
Candesartan—Urticaria—Mycophenolate mofetil—psoriasis	0.000226	0.000814	CcSEcCtD
Candesartan—ABCB1—Allograft Rejection—IL17A—psoriasis	0.000226	0.00419	CbGpPWpGaD
Candesartan—Headache—Mycophenolic acid—psoriasis	0.000225	0.000814	CcSEcCtD
Candesartan—Pharyngitis—Methotrexate—psoriasis	0.000225	0.000811	CcSEcCtD
Candesartan—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000224	0.00081	CcSEcCtD
Candesartan—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000224	0.00081	CcSEcCtD
Candesartan—Urinary tract disorder—Methotrexate—psoriasis	0.000224	0.000807	CcSEcCtD
Candesartan—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000223	0.000806	CcSEcCtD
Candesartan—Fatigue—Hydrocortisone—psoriasis	0.000223	0.000805	CcSEcCtD
Candesartan—Urethral disorder—Methotrexate—psoriasis	0.000222	0.000801	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000222	0.000801	CcSEcCtD
Candesartan—Paraesthesia—Triamcinolone—psoriasis	0.000219	0.00079	CcSEcCtD
Candesartan—Anaemia—Prednisone—psoriasis	0.000218	0.000787	CcSEcCtD
Candesartan—Dyspnoea—Triamcinolone—psoriasis	0.000217	0.000784	CcSEcCtD
Candesartan—Thrombocytopenia—Betamethasone—psoriasis	0.000216	0.000781	CcSEcCtD
Candesartan—Thrombocytopenia—Dexamethasone—psoriasis	0.000216	0.000781	CcSEcCtD
Candesartan—Tachycardia—Betamethasone—psoriasis	0.000216	0.000779	CcSEcCtD
Candesartan—Tachycardia—Dexamethasone—psoriasis	0.000216	0.000779	CcSEcCtD
Candesartan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000216	0.004	CbGpPWpGaD
Candesartan—Angioedema—Prednisone—psoriasis	0.000216	0.000778	CcSEcCtD
Candesartan—Dyspepsia—Triamcinolone—psoriasis	0.000214	0.000774	CcSEcCtD
Candesartan—Nausea—Mycophenolic acid—psoriasis	0.000214	0.000772	CcSEcCtD
Candesartan—Hyperhidrosis—Dexamethasone—psoriasis	0.000214	0.000771	CcSEcCtD
Candesartan—Hyperhidrosis—Betamethasone—psoriasis	0.000214	0.000771	CcSEcCtD
Candesartan—Vertigo—Prednisone—psoriasis	0.000212	0.000765	CcSEcCtD
Candesartan—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000212	0.000764	CcSEcCtD
Candesartan—Urticaria—Prednisolone—psoriasis	0.00021	0.00076	CcSEcCtD
Candesartan—PTGS1—Selenium Micronutrient Network—CRP—psoriasis	0.00021	0.0039	CbGpPWpGaD
Candesartan—Fatigue—Triamcinolone—psoriasis	0.00021	0.000758	CcSEcCtD
Candesartan—ABCB1—Allograft Rejection—IL12B—psoriasis	0.00021	0.00389	CbGpPWpGaD
Candesartan—Asthenia—Cyclosporine—psoriasis	0.000209	0.000754	CcSEcCtD
Candesartan—Hypotension—Dexamethasone—psoriasis	0.000207	0.000746	CcSEcCtD
Candesartan—Hypotension—Betamethasone—psoriasis	0.000207	0.000746	CcSEcCtD
Candesartan—Pruritus—Cyclosporine—psoriasis	0.000206	0.000744	CcSEcCtD
Candesartan—Urticaria—Hydrocortisone—psoriasis	0.000206	0.000742	CcSEcCtD
Candesartan—ABCB1—Allograft Rejection—HLA-E—psoriasis	0.000205	0.0038	CbGpPWpGaD
Candesartan—Body temperature increased—Hydrocortisone—psoriasis	0.000205	0.000738	CcSEcCtD
Candesartan—Abdominal pain—Hydrocortisone—psoriasis	0.000205	0.000738	CcSEcCtD
Candesartan—Asthenia—Mycophenolate mofetil—psoriasis	0.000204	0.000736	CcSEcCtD
Candesartan—Hypertension—Prednisone—psoriasis	0.000204	0.000735	CcSEcCtD
Candesartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000201	0.00374	CbGpPWpGaD
Candesartan—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000201	0.000727	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000201	0.000727	CcSEcCtD
Candesartan—Pruritus—Mycophenolate mofetil—psoriasis	0.000201	0.000725	CcSEcCtD
Candesartan—Myalgia—Prednisone—psoriasis	0.000201	0.000725	CcSEcCtD
Candesartan—Arthralgia—Prednisone—psoriasis	0.000201	0.000725	CcSEcCtD
Candesartan—Anxiety—Prednisone—psoriasis	0.0002	0.000722	CcSEcCtD
Candesartan—Diarrhoea—Cyclosporine—psoriasis	0.000199	0.000719	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—TNF—psoriasis	0.000199	0.00369	CbGpPWpGaD
Candesartan—Paraesthesia—Dexamethasone—psoriasis	0.000198	0.000717	CcSEcCtD
Candesartan—Paraesthesia—Betamethasone—psoriasis	0.000198	0.000717	CcSEcCtD
Candesartan—Mental disorder—Methotrexate—psoriasis	0.000198	0.000716	CcSEcCtD
Candesartan—Malnutrition—Methotrexate—psoriasis	0.000197	0.000712	CcSEcCtD
Candesartan—Dyspepsia—Betamethasone—psoriasis	0.000195	0.000702	CcSEcCtD
Candesartan—Dyspepsia—Dexamethasone—psoriasis	0.000195	0.000702	CcSEcCtD
Candesartan—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000194	0.000701	CcSEcCtD
Candesartan—Urticaria—Triamcinolone—psoriasis	0.000194	0.000699	CcSEcCtD
Candesartan—PTGS1—Selenium Micronutrient Network—ICAM1—psoriasis	0.000193	0.00358	CbGpPWpGaD
Candesartan—Body temperature increased—Triamcinolone—psoriasis	0.000193	0.000695	CcSEcCtD
Candesartan—Dizziness—Cyclosporine—psoriasis	0.000192	0.000695	CcSEcCtD
Candesartan—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000191	0.000689	CcSEcCtD
Candesartan—Gastrointestinal disorder—Betamethasone—psoriasis	0.000191	0.000689	CcSEcCtD
Candesartan—Back pain—Methotrexate—psoriasis	0.000191	0.000688	CcSEcCtD
Candesartan—Fatigue—Dexamethasone—psoriasis	0.000191	0.000688	CcSEcCtD
Candesartan—Fatigue—Betamethasone—psoriasis	0.000191	0.000688	CcSEcCtD
Candesartan—Tachycardia—Prednisone—psoriasis	0.000188	0.000678	CcSEcCtD
Candesartan—Dizziness—Mycophenolate mofetil—psoriasis	0.000188	0.000678	CcSEcCtD
Candesartan—Hyperhidrosis—Prednisone—psoriasis	0.000186	0.000672	CcSEcCtD
Candesartan—Asthenia—Hydrocortisone—psoriasis	0.000186	0.00067	CcSEcCtD
Candesartan—Vomiting—Cyclosporine—psoriasis	0.000185	0.000668	CcSEcCtD
Candesartan—UGT1A3—Metabolism—NDUFA5—psoriasis	0.000184	0.00342	CbGpPWpGaD
Candesartan—Rash—Cyclosporine—psoriasis	0.000184	0.000663	CcSEcCtD
Candesartan—Dermatitis—Cyclosporine—psoriasis	0.000183	0.000662	CcSEcCtD
Candesartan—Pruritus—Hydrocortisone—psoriasis	0.000183	0.000661	CcSEcCtD
Candesartan—Headache—Cyclosporine—psoriasis	0.000182	0.000658	CcSEcCtD
Candesartan—Anaemia—Methotrexate—psoriasis	0.000182	0.000658	CcSEcCtD
Candesartan—Gastrointestinal pain—Dexamethasone—psoriasis	0.000181	0.000653	CcSEcCtD
Candesartan—Gastrointestinal pain—Betamethasone—psoriasis	0.000181	0.000653	CcSEcCtD
Candesartan—Vomiting—Mycophenolate mofetil—psoriasis	0.000181	0.000652	CcSEcCtD
Candesartan—Rash—Mycophenolate mofetil—psoriasis	0.000179	0.000646	CcSEcCtD
Candesartan—Dermatitis—Mycophenolate mofetil—psoriasis	0.000179	0.000646	CcSEcCtD
Candesartan—Headache—Mycophenolate mofetil—psoriasis	0.000178	0.000642	CcSEcCtD
Candesartan—Vertigo—Methotrexate—psoriasis	0.000177	0.000639	CcSEcCtD
Candesartan—Diarrhoea—Hydrocortisone—psoriasis	0.000177	0.000639	CcSEcCtD
Candesartan—Leukopenia—Methotrexate—psoriasis	0.000176	0.000637	CcSEcCtD
Candesartan—Urticaria—Dexamethasone—psoriasis	0.000176	0.000634	CcSEcCtD
Candesartan—Urticaria—Betamethasone—psoriasis	0.000176	0.000634	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Prednisone—psoriasis	0.000175	0.000633	CcSEcCtD
Candesartan—Dizziness—Prednisolone—psoriasis	0.000175	0.000632	CcSEcCtD
Candesartan—Asthenia—Triamcinolone—psoriasis	0.000175	0.000631	CcSEcCtD
Candesartan—Abdominal pain—Dexamethasone—psoriasis	0.000175	0.000631	CcSEcCtD
Candesartan—Abdominal pain—Betamethasone—psoriasis	0.000175	0.000631	CcSEcCtD
Candesartan—Body temperature increased—Betamethasone—psoriasis	0.000175	0.000631	CcSEcCtD
Candesartan—Body temperature increased—Dexamethasone—psoriasis	0.000175	0.000631	CcSEcCtD
Candesartan—Nausea—Cyclosporine—psoriasis	0.000173	0.000624	CcSEcCtD
Candesartan—Paraesthesia—Prednisone—psoriasis	0.000173	0.000624	CcSEcCtD
Candesartan—Pruritus—Triamcinolone—psoriasis	0.000172	0.000622	CcSEcCtD
Candesartan—Cough—Methotrexate—psoriasis	0.000172	0.000621	CcSEcCtD
Candesartan—Dizziness—Hydrocortisone—psoriasis	0.000171	0.000618	CcSEcCtD
Candesartan—Dyspepsia—Prednisone—psoriasis	0.000169	0.000612	CcSEcCtD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	0.000169	0.00314	CbGpPWpGaD
Candesartan—Nausea—Mycophenolate mofetil—psoriasis	0.000169	0.000609	CcSEcCtD
Candesartan—Myalgia—Methotrexate—psoriasis	0.000168	0.000606	CcSEcCtD
Candesartan—Chest pain—Methotrexate—psoriasis	0.000168	0.000606	CcSEcCtD
Candesartan—Arthralgia—Methotrexate—psoriasis	0.000168	0.000606	CcSEcCtD
Candesartan—Rash—Prednisolone—psoriasis	0.000167	0.000603	CcSEcCtD
Candesartan—Dermatitis—Prednisolone—psoriasis	0.000167	0.000602	CcSEcCtD
Candesartan—Fatigue—Prednisone—psoriasis	0.000166	0.000599	CcSEcCtD
Candesartan—Headache—Prednisolone—psoriasis	0.000166	0.000599	CcSEcCtD
Candesartan—Vomiting—Hydrocortisone—psoriasis	0.000164	0.000594	CcSEcCtD
Candesartan—Rash—Hydrocortisone—psoriasis	0.000163	0.000589	CcSEcCtD
Candesartan—Dermatitis—Hydrocortisone—psoriasis	0.000163	0.000588	CcSEcCtD
Candesartan—Headache—Hydrocortisone—psoriasis	0.000162	0.000585	CcSEcCtD
Candesartan—Dizziness—Triamcinolone—psoriasis	0.000161	0.000582	CcSEcCtD
Candesartan—Asthenia—Dexamethasone—psoriasis	0.000159	0.000573	CcSEcCtD
Candesartan—Asthenia—Betamethasone—psoriasis	0.000159	0.000573	CcSEcCtD
Candesartan—Thrombocytopenia—Methotrexate—psoriasis	0.000158	0.000569	CcSEcCtD
Candesartan—Gastrointestinal pain—Prednisone—psoriasis	0.000157	0.000568	CcSEcCtD
Candesartan—Nausea—Prednisolone—psoriasis	0.000157	0.000568	CcSEcCtD
Candesartan—UGT1A3—Metabolism—CYP2S1—psoriasis	0.000156	0.0029	CbGpPWpGaD
Candesartan—Pruritus—Betamethasone—psoriasis	0.000156	0.000565	CcSEcCtD
Candesartan—Pruritus—Dexamethasone—psoriasis	0.000156	0.000565	CcSEcCtD
Candesartan—AGTR1—Signaling Pathways—HCAR2—psoriasis	0.000156	0.0029	CbGpPWpGaD
Candesartan—Hyperhidrosis—Methotrexate—psoriasis	0.000156	0.000561	CcSEcCtD
Candesartan—Vomiting—Triamcinolone—psoriasis	0.000155	0.000559	CcSEcCtD
Candesartan—Nausea—Hydrocortisone—psoriasis	0.000154	0.000555	CcSEcCtD
Candesartan—Rash—Triamcinolone—psoriasis	0.000154	0.000555	CcSEcCtD
Candesartan—Dermatitis—Triamcinolone—psoriasis	0.000153	0.000554	CcSEcCtD
Candesartan—ABCB1—Allograft Rejection—IL10—psoriasis	0.000153	0.00285	CbGpPWpGaD
Candesartan—Urticaria—Prednisone—psoriasis	0.000153	0.000552	CcSEcCtD
Candesartan—Headache—Triamcinolone—psoriasis	0.000153	0.000551	CcSEcCtD
Candesartan—Body temperature increased—Prednisone—psoriasis	0.000152	0.000549	CcSEcCtD
Candesartan—Abdominal pain—Prednisone—psoriasis	0.000152	0.000549	CcSEcCtD
Candesartan—AGTR1—GPCR downstream signaling—CCL20—psoriasis	0.000151	0.00281	CbGpPWpGaD
Candesartan—Diarrhoea—Betamethasone—psoriasis	0.000151	0.000546	CcSEcCtD
Candesartan—Diarrhoea—Dexamethasone—psoriasis	0.000151	0.000546	CcSEcCtD
Candesartan—Hypotension—Methotrexate—psoriasis	0.00015	0.000543	CcSEcCtD
Candesartan—ABCB1—Allograft Rejection—IL4—psoriasis	0.000149	0.00277	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	0.000147	0.00273	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—IFNG—psoriasis	0.000147	0.00273	CbGpPWpGaD
Candesartan—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000147	0.000529	CcSEcCtD
Candesartan—Dizziness—Dexamethasone—psoriasis	0.000146	0.000528	CcSEcCtD
Candesartan—Dizziness—Betamethasone—psoriasis	0.000146	0.000528	CcSEcCtD
Candesartan—ABCB1—Allograft Rejection—HLA-B—psoriasis	0.000146	0.00271	CbGpPWpGaD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	0.000146	0.0027	CbGpPWpGaD
Candesartan—Nausea—Triamcinolone—psoriasis	0.000145	0.000522	CcSEcCtD
Candesartan—Paraesthesia—Methotrexate—psoriasis	0.000144	0.000521	CcSEcCtD
Candesartan—Dyspnoea—Methotrexate—psoriasis	0.000143	0.000518	CcSEcCtD
Candesartan—Somnolence—Methotrexate—psoriasis	0.000143	0.000516	CcSEcCtD
Candesartan—Dyspepsia—Methotrexate—psoriasis	0.000142	0.000511	CcSEcCtD
Candesartan—AGTR1—Peptide ligand-binding receptors—CXCL8—psoriasis	0.000142	0.00263	CbGpPWpGaD
Candesartan—Vomiting—Betamethasone—psoriasis	0.000141	0.000507	CcSEcCtD
Candesartan—Vomiting—Dexamethasone—psoriasis	0.000141	0.000507	CcSEcCtD
Candesartan—Rash—Betamethasone—psoriasis	0.000139	0.000503	CcSEcCtD
Candesartan—Rash—Dexamethasone—psoriasis	0.000139	0.000503	CcSEcCtD
Candesartan—Dermatitis—Betamethasone—psoriasis	0.000139	0.000503	CcSEcCtD
Candesartan—Dermatitis—Dexamethasone—psoriasis	0.000139	0.000503	CcSEcCtD
Candesartan—Gastrointestinal disorder—Methotrexate—psoriasis	0.000139	0.000501	CcSEcCtD
Candesartan—Fatigue—Methotrexate—psoriasis	0.000139	0.000501	CcSEcCtD
Candesartan—Headache—Dexamethasone—psoriasis	0.000138	0.0005	CcSEcCtD
Candesartan—Headache—Betamethasone—psoriasis	0.000138	0.0005	CcSEcCtD
Candesartan—Asthenia—Prednisone—psoriasis	0.000138	0.000499	CcSEcCtD
Candesartan—AGTR1—Signaling by GPCR—CCL20—psoriasis	0.000137	0.00255	CbGpPWpGaD
Candesartan—Pruritus—Prednisone—psoriasis	0.000136	0.000492	CcSEcCtD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	0.000136	0.00252	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TAGAP—psoriasis	0.000135	0.00251	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—HLA-A—psoriasis	0.000135	0.00251	CbGpPWpGaD
Candesartan—Diarrhoea—Prednisone—psoriasis	0.000132	0.000475	CcSEcCtD
Candesartan—Gastrointestinal pain—Methotrexate—psoriasis	0.000132	0.000475	CcSEcCtD
Candesartan—Nausea—Dexamethasone—psoriasis	0.000131	0.000474	CcSEcCtD
Candesartan—Nausea—Betamethasone—psoriasis	0.000131	0.000474	CcSEcCtD
Candesartan—Urticaria—Methotrexate—psoriasis	0.000128	0.000461	CcSEcCtD
Candesartan—Dizziness—Prednisone—psoriasis	0.000127	0.00046	CcSEcCtD
Candesartan—Abdominal pain—Methotrexate—psoriasis	0.000127	0.000459	CcSEcCtD
Candesartan—Body temperature increased—Methotrexate—psoriasis	0.000127	0.000459	CcSEcCtD
Candesartan—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	0.000123	0.00229	CbGpPWpGaD
Candesartan—Vomiting—Prednisone—psoriasis	0.000122	0.000442	CcSEcCtD
Candesartan—PTGS1—Selenium Micronutrient Network—NFKB1—psoriasis	0.000122	0.00227	CbGpPWpGaD
Candesartan—Rash—Prednisone—psoriasis	0.000121	0.000438	CcSEcCtD
Candesartan—Dermatitis—Prednisone—psoriasis	0.000121	0.000438	CcSEcCtD
Candesartan—Headache—Prednisone—psoriasis	0.000121	0.000435	CcSEcCtD
Candesartan—Asthenia—Methotrexate—psoriasis	0.000115	0.000417	CcSEcCtD
Candesartan—Nausea—Prednisone—psoriasis	0.000114	0.000413	CcSEcCtD
Candesartan—Pruritus—Methotrexate—psoriasis	0.000114	0.000411	CcSEcCtD
Candesartan—Diarrhoea—Methotrexate—psoriasis	0.00011	0.000397	CcSEcCtD
Candesartan—Dizziness—Methotrexate—psoriasis	0.000106	0.000384	CcSEcCtD
Candesartan—PTGS1—Metabolism—NDUFA5—psoriasis	0.000104	0.00192	CbGpPWpGaD
Candesartan—Vomiting—Methotrexate—psoriasis	0.000102	0.000369	CcSEcCtD
Candesartan—Rash—Methotrexate—psoriasis	0.000101	0.000366	CcSEcCtD
Candesartan—Dermatitis—Methotrexate—psoriasis	0.000101	0.000366	CcSEcCtD
Candesartan—Headache—Methotrexate—psoriasis	0.000101	0.000364	CcSEcCtD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	9.66e-05	0.00179	CbGpPWpGaD
Candesartan—Nausea—Methotrexate—psoriasis	9.56e-05	0.000345	CcSEcCtD
Candesartan—PTGS1—Selenium Micronutrient Network—TNF—psoriasis	9.51e-05	0.00177	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	9.49e-05	0.00176	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IFNG—psoriasis	9.01e-05	0.00167	CbGpPWpGaD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	9e-05	0.00167	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CYP2S1—psoriasis	8.81e-05	0.00164	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—CXCL8—psoriasis	8.38e-05	0.00156	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCL20—psoriasis	8.11e-05	0.00151	CbGpPWpGaD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	7.86e-05	0.00146	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—IL6—psoriasis	7.67e-05	0.00142	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CARM1—psoriasis	7.64e-05	0.00142	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—CXCL8—psoriasis	7.23e-05	0.00134	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	7.2e-05	0.00134	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	6.9e-05	0.00128	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—VEGFA—psoriasis	6.81e-05	0.00126	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—NDUFA5—psoriasis	6.69e-05	0.00124	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	6.24e-05	0.00116	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—TNF—psoriasis	5.83e-05	0.00108	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—NDUFA5—psoriasis	5.83e-05	0.00108	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	5.8e-05	0.00108	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CYP2S1—psoriasis	5.69e-05	0.00106	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—NDUFA5—psoriasis	5.45e-05	0.00101	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	5.42e-05	0.00101	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	5.17e-05	0.00096	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	5.08e-05	0.000943	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CYP2S1—psoriasis	4.96e-05	0.00092	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CAT—psoriasis	4.7e-05	0.000872	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CYP2S1—psoriasis	4.63e-05	0.00086	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.62e-05	0.000857	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SOCS1—psoriasis	4.47e-05	0.000829	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CARM1—psoriasis	4.3e-05	0.000799	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—TYK2—psoriasis	4.26e-05	0.000791	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CXCL8—psoriasis	4.08e-05	0.000758	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.02e-05	0.000747	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	3.85e-05	0.000714	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CXCL8—psoriasis	3.71e-05	0.000689	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	3.7e-05	0.000687	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—APOE—psoriasis	3.65e-05	0.000678	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	3.36e-05	0.000623	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—APOE—psoriasis	3.3e-05	0.000612	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—LEP—psoriasis	3.3e-05	0.000612	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PPARG—psoriasis	3.18e-05	0.00059	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NFKBIA—psoriasis	3.07e-05	0.00057	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.98e-05	0.000554	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	2.88e-05	0.000534	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CARM1—psoriasis	2.78e-05	0.000516	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CAT—psoriasis	2.65e-05	0.000491	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.6e-05	0.000482	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	2.54e-05	0.000471	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TYK2—psoriasis	2.52e-05	0.000467	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.43e-05	0.000451	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CARM1—psoriasis	2.42e-05	0.000449	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CARM1—psoriasis	2.26e-05	0.00042	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CXCL8—psoriasis	2.19e-05	0.000407	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.11e-05	0.000393	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IL6—psoriasis	2.08e-05	0.000387	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—APOE—psoriasis	2.06e-05	0.000382	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—JUN—psoriasis	2.04e-05	0.000378	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NFKB1—psoriasis	1.96e-05	0.000364	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PPARG—psoriasis	1.79e-05	0.000333	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—VEGFA—psoriasis	1.78e-05	0.00033	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—STAT3—psoriasis	1.76e-05	0.000327	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CAT—psoriasis	1.71e-05	0.000317	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CAT—psoriasis	1.49e-05	0.000276	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CAT—psoriasis	1.39e-05	0.000258	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TP53—psoriasis	1.34e-05	0.00025	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—APOE—psoriasis	1.33e-05	0.000247	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL6—psoriasis	1.23e-05	0.000228	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—APOE—psoriasis	1.16e-05	0.000215	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PPARG—psoriasis	1.16e-05	0.000215	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—APOE—psoriasis	1.08e-05	0.000201	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PPARG—psoriasis	1.01e-05	0.000187	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PPARG—psoriasis	9.42e-06	0.000175	CbGpPWpGaD
